Attached files

file filename
8-K - FORM 8-K - Aeon Global Health Corp.d8k.htm

Exhibit 99.1

LOGO

FOR IMMEDIATE RELEASE

For: Authentidate Holding Corp.

Investor Contacts:

Robert Schatz

Wolfe Axelrod Weinberger Assoc. LLC

(212) 370-4500; (212) 370-4505 fax

AUTHENTIDATE HOLDING CORP. REPORTS FISCAL 2011 SECOND QUARTER RESULTS

BERKELEY HEIGHTS, NJ – February 10, 2011 — Authentidate Holding Corp. (Nasdaq: ADAT), a worldwide provider of secure health information exchange, workflow management services and telehealth solutions, today announced financial results for the three and six month periods ended December 31, 2010.

Selected highlights for the six month period ended December 31, 2010 include:

 

   

Added several new projects for Inscrybe® Healthcare and ExpressMD’s Electronic House Call™ telehealth solution, including Visiting Nursing Association of Western New York, Chicago VNA, Inc., Lehigh Valley Respiratory Care, Primary Wound Care and a telehealth distribution agreement with Rotech Healthcare Inc. that have been announced.

 

   

Increased U.S. revenues for the quarter and six month periods over the same periods last year and, excluding the non-cash goodwill impairment charge discussed below, reduced operating and net loss amounts for the current year periods.

 

   

Announced a settlement agreement that, if final approval is granted by the court, resolves the shareholder class action suit.

 

   

Strengthened our balance sheet with the sale of certain non-core assets in July 2010 for net proceeds of approximately $2.35 million and the private placement of the company’s securities in October 2010 for net proceeds of approximately $4.46 million.

Ben Benjamin, President of Authentidate, stated “Over the past two quarters we have made progress on multiple fronts, including marketing our Inscrybe® Healthcare, telehealth, and hospital discharge solutions, and continue to open new doors for future sales. Stemming from this progress, our U.S. revenues have improved during fiscal 2011 due to increases in transaction volumes and new customer projects. In addition, we have continued to manage our operating expenses which has resulted in improved operating results for the current periods before considering the non-cash goodwill impairment charge we incurred in the quarter ended December 31, 2010. This charge relates to our German operations and is based on an updated analysis of current operating results, revised expectations for future growth and uncertainty regarding the recovery of the market for comparable assets.”

Mr. Benjamin continued, “While the economic environment has been challenging, we believe there is strong demand for our services and solutions as healthcare providers search for ways to reduce administrative and patient care costs. We continue to experience increased customer inquiries for our solutions and have been successful in converting several of these inquires into new projects. We believe that we are making strides in the telehealth arena and we have made a positive impact in awareness of our solutions given the rise in inquiries received in recent months. We continue to monitor significant opportunities in our marketplace and will update shareholders as they develop. In the interim, we believe we are well positioned for the remainder of fiscal 2011 and, while no assurances can be given, we believe we have sufficient working capital and available resources to fund our operations for the next 12 months as we focus on our various growth opportunities for our Inscrybe® Healthcare, hospital discharge and ExpressMD products and services.”

- More -


Total revenue for the three months ended December 31, 2010 was approximately $1,578,000 compared to $1,528,000 for the same period last year. These results reflect an increase of approximately 12% in U.S. revenues from increases in transaction volumes and new customer projects which was partially offset by a decrease in revenues from our German operations due primarily to the timing of certain contract awards and project implementations and, to a lesser extent, a shift to more transaction-based software-as-a-service projects. Compared to the first quarter of fiscal 2011, total revenue increased approximately 16% reflecting higher revenues in both the U.S. and Germany for the current period.

Net loss for the second quarter of fiscal 2011, including a non-cash goodwill impairment charge of $5,400,000 related to our German operations, increased to $7,275,000, or $0.16 per share, compared to $2,819,000, or $0.08 per share, for the prior year period. The net loss for the period reflects higher U.S. revenues and lower expenses from our cost management activities, which were offset by the goodwill impairment charge and lower revenues from our German operations. The prior year period included a non-cash expense of $533,000 to amortize deferred financing costs.

Total revenue for the six months ended December 31, 2010 was approximately $2,940,000 compared to $3,550,000 for the prior year period. These results include an increase of approximately 20% in U.S. revenues which was offset by lower revenues from our German operations reflecting the same trends as the second quarter.

Net loss for the six months ended December 31, 2010, including the goodwill impairment charge, was $8,872,000, or $0.22 per share, compared to $4,932,000, or $0.14 per share, for the prior year period. The net loss for the period primarily reflects the same trends as the second quarter and the gain on the sale of certain non-core assets in the first quarter.

As of December 31, 2010, cash, cash equivalents and marketable securities totaled $4,096,000, working capital was approximately $6,214,000 and deferred revenue totaled $1,113,000.

About Authentidate Holding Corp.

Authentidate Holding Corp. is a worldwide provider of secure health information exchange, workflow management services and telehealth solutions. The company’s software and web-based services enable healthcare organizations and other enterprises to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. The web-based services are delivered as Software as a Service (SaaS), and only require that customers have an Internet connection and web browser. The company’s healthcare customers and users include leading homecare companies, health systems and physician groups. These organizations utilize the company’s products and services to coordinate care for patients outside of acute-care.

The company has offices in the United States and Germany.

For more information, visit the company’s website at http://www.authentidate.com/

About ExpressMD Solutions

ExpressMD Solutions is a joint venture formed by Authentidate Holding Corp. (Nasdaq: ADAT) and Encountercare Solutions (ECSL) to provide web-based telehealth services and home healthcare equipment dedicated to the advancement of in-home patient healthcare and improved chronic condition outcomes.

The complete ExpressMD telehealth solution combines Electronic House Call, an FDA 510(k) market clearance approved, in-home patient vital signs monitoring system with a web application that streamlines the practitioner’s job anywhere they have Internet or a Windows mobile communication device.

For more information about ExpressMD Solutions, visit www.expressmdsolutions.com

This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this release, the words “believe,” “anticipate,” “think,” “intend,” “plan,” “will be,” “expect,” and similar expressions identify such forward-looking statements. Such statements regarding future events and/or the future financial


performance of the company are subject to certain risks and uncertainties, which could cause actual events or the actual future results of the company to differ materially from any forward-looking statement. Such risks and uncertainties include, among other things, the availability of any needed financing, the company’s ability to implement its business plan for various applications of its technologies, the impact of competition, the management of growth, and the other risks and uncertainties that may be detailed from time to time in the company’s reports filed with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved.

Authentidate and Inscrybe are registered trademarks of Authentidate Holding Corp. All other trade names are the property of their respective owners.

- Tables to Follow -


Authentidate Holding Corp. and Subsidiaries

Condensed Consolidated Balance Sheet Data

(in thousands, except per share data)

 

     December 31,
2010
    June 30,  
     (Unaudited)     2010  

Assets

    

Current assets

    

Cash and cash equivalents

   $ 3,116      $ 433   

Restricted cash

     256        256   

Marketable securities

     980        1,079   

Accounts receivable, net

     1,092        1,138   

Inventory

     4,756        4,589   

Prepaid expenses and other current assets

     845        585   
                

Total current assets

     11,045        8,080   

Property and equipment, net

     432        553   

Other assets

    

Software development costs, net

     1,081        1,467   

Goodwill

     1,941        7,341   

Other assets

     1,052        1,103   

Assets held for sale

     —          2,000   
                

Total assets

   $ 15,551      $ 20,544   
                

Liabilities, Redeemable Preferred Stock and Shareholders’ Equity

    

Current liabilities

    

Accounts payable and accrued expenses

   $ 3,724      $ 4,457   

Deferred revenue

     973        942   

Other current liabilities

     134        127   
                

Total current liabilities

     4,831        5,526   

Long-term deferred revenue

     140        140   
                

Total liabilities

     4,971        5,666   
                

Commitments and contingencies

    

Redeemable preferred stock

     2,783        —     

Shareholders’ equity

    

Preferred stock $.10 par value; 5,000 shares authorized Series B, 28 shares issued and outstanding on June 30, 2010

     —          3   

Common stock, $.001 par value; 75,000 shares authorized, 45,986 and 38,436 issued and outstanding on December 31, 2010 and June 30, 2010, respectively

     46        38   

Additional paid-in capital

     172,362        170,490   

Accumulated deficit

     (164,491     (155,518

Accumulated other comprehensive loss

     (120     (135
                

Total shareholders’ equity

     7,797        14,878   
                

Total liabilities, redeemable preferred stock and shareholders’ equity

   $ 15,551      $ 20,544   
                

- More -


Authentidate Holding Corp. and Subsidiaries

Condensed Consolidated Statements of Operations Data

(Unaudited)

(in thousands, except per share data)

 

     Three Months Ended
December 31,
    Six Months Ended
December 31,
 
     2010     2009     2010     2009  

Revenues

        

Software licenses and support

   $ 880      $ 904      $ 1,562      $ 2,400   

Hosted software services

     698        624        1,378        1,150   
                                

Total revenues

     1,578        1,528        2,940        3,550   
                                

Operating expenses

        

Cost of revenues

     766        676        1,358        1,546   

Selling, general and administrative

     1,998        2,480        4,031        5,058   

Product development

     396        470        806        977   

Depreciation and amortization

     293        273        583        547   

Goodwill impairment

     5,400        —          5,400        —     
                                

Total operating expenses

     8,853        3,899        12,178        8,128   
                                

Operating loss

     (7,275     (2,371     (9,238     (4,578

Other income (expense), net

     —          (448     366        (354
                                

Net loss

   $ (7,275   $ (2,819   $ (8,872   $ (4,932
                                

Basic and diluted loss per common share

   $ (0.16   $ (0.08   $ (0.22   $ (0.14
                                

###